Amy C. Peterson

Insider Reports History

Location
Camana Bay, Grand Cayman, Cayman Islands
Signature
/s/ Nina Ayer, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy C. Peterson:

Company Role Class Num Shares Value Price $ Report Date Ownership
EXELIXIS, INC. EVP Prod Dev & Med Aff & CMO Common Stock 465,393 $21,161,419 $45.47 16 May 2025 Direct
CytomX Therapeutics, Inc. EVP, Chief Development Officer Common Stock 58,433 $80,678 $1.38 16 Mar 2023 Direct
EXELIXIS, INC. EVP Prod Dev & Med Aff & CMO Option (right to buy) 120,000 16 May 2025 Direct

Insider Reports Filed by Amy C. Peterson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EXEL EXELIXIS, INC. 15 May 2025 4 -$2,809,854 4 EVP Prod Dev & Med Aff & CMO 16 May 2025, 20:57
EXEL EXELIXIS, INC. 31 Mar 2025 1 $0 4 EVP Prod Dev & Med Aff & CMO 31 Mar 2025, 19:43
EXEL EXELIXIS, INC. 26 Feb 2025 1 $0 4 EVP Prod Dev & Med Aff & CMO 28 Feb 2025, 20:34
EXEL EXELIXIS, INC. 15 Nov 2024 1 -$954,201 4 EVP Prod Dev & Med Aff & CMO 19 Nov 2024, 20:02
EXEL EXELIXIS, INC. 23 Feb 2024 1 $0 4 EVP Prod Dev & Med Aff & CMO 27 Feb 2024, 18:59
EXEL EXELIXIS, INC. 24 Aug 2023 2 $0 4 EVP Prod Dev & Med Aff & CMO 25 Aug 2023, 20:40
EXEL EXELIXIS, INC. 24 Aug 2023 0 $0 3 EVP Prod Dev & Med Aff & CMO 25 Aug 2023, 20:39
CTMX CytomX Therapeutics, Inc. 16 Mar 2023 1 -$8,425 4 EVP, Chief Development Officer 20 Mar 2023, 18:43
CTMX CytomX Therapeutics, Inc. 19 Jul 2022 2 -$10,612 4 EVP, Chief Development Officer 21 Jul 2022, 16:11
CTMX CytomX Therapeutics, Inc. 02 Feb 2022 2 $0 4 EVP, Chief Development Officer 04 Feb 2022, 15:53
CTMX CytomX Therapeutics, Inc. 24 Oct 2021 2 $0 4 EVP, Chief Development Officer 26 Oct 2021, 16:26
CTMX CytomX Therapeutics, Inc. 31 May 2021 1 +$20,206 4 EVP, Chief Development Officer 08 Jun 2021, 13:07